Columbia Cancer

@columbiacancer

The Twitter account of the Herbert Irving Comprehensive Cancer Center at /. Call 212-851-4680 for more information.

New York, NY
Vrijeme pridruživanja: listopad 2013.

Tweetovi

Blokirali ste korisnika/cu @columbiacancer

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @columbiacancer

  1. Poništi
  2. This , join us as we work to reduce the burden of cancer on our patients, their families, our community, and the world. CC: /

    Poništi
  3. proslijedio/la je Tweet
    4. velj

    . of and highlights recent developments in triple-negative , including the potential role of in the neoadjuvant setting

    Poništi
  4. 3. velj

    Luspatercept reduced the severity of anemia in patients with lower-risk myelodysplastic syndromes. Dr. Joseph Jurcic of and colleagues share results from a phase 3 trial in .

    Poništi
  5. 1. velj

    : The first article in the new journal "Blood Cancer Discovery" has been published, and our own Riccardo Dalla-Favera is Editor-In-Chief! "Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia"

    Poništi
  6. 31. sij

    Our more than 180 members at the span six schools and 35 departments across and . Read more about how our researchers and physicians are translating discovery science into cutting-edge cancer care.

    Poništi
  7. 31. sij

    At the , our discoveries change lives. Read our 2019 annual report, "Accelerating Towards A Cure."

    Poništi
  8. proslijedio/la je Tweet
    31. sij

    We are proud that we finished GeriTalk (1-day communication skills training from ) today. This is our 3rd year. Trained 8 fellows and 1 surgeon. Very fulfilling experience!

    Poništi
  9. 30. sij

    Congratulations to our own Dr. Arnold Han, who has been awarded the Rachleff Innovation Award from the Foundation for research with the potential to significantly impact the prevention, diagnosis, and treatment of .

    Poništi
  10. 29. sij

    How have and researchers advanced our understanding of the effect? Sreyan Chowdhury () shares with .

    Poništi
  11. proslijedio/la je Tweet
    23. sij

    Trained 8 critical care fellows for communication (CriticalTalk, derived from ). It was just a short 2h session, but still there were lots of learning. Only practice makes perfect! Appreciate the support by

    Poništi
  12. 28. sij

    At the 2020 Pancreas Symposium, hosted by the Pancreas Center at , experts from / will review cutting-edge diagnostics and treatments and what's on the horizon for pancreas diseases. Register below:

    Poništi
  13. proslijedio/la je Tweet
    24. sij

    Today I participated in a symposium organized by and as a new initiative to promote new collaborations between cancer and engineering research at . Shout-out to and Mary Boyce for organizing and for great talks!

    Poništi
  14. 27. sij

    "This approval of Tazverik (tazemetostat) represents an important advancement in the treatment of patients with epitheliod sarcoma," says / oncologist Gary Schwartz. Read more via :

    Poništi
  15. 25. sij

    Congratulations to Steve Sastra - very well-deserved recognition for his leadership of the Mouse Hospital, an innovative facility within the designed to recreate all aspects of a clinical trial while using mouse models.

    Poništi
  16. proslijedio/la je Tweet

    Thank you ! immunotherapy is a growing field and understanding biomarkers to improve treatment response is key. We started our first steps in melanoma now we battle children’s cancer.

    Poništi
  17. 23. sij

    What are the warning signs of ? Learn more from / gynecologic oncologist Dr. Caryn St. Clair.

    Poništi
  18. proslijedio/la je Tweet
    22. sij
    Poništi
  19. 22. sij

    What has -MATCH trial taught us about ? Read more about how the NCI-MATCH trial is helping researchers and physicians navigate the complexities of molecular profiling for targeted therapies.

    Poništi
  20. proslijedio/la je Tweet
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·